Table 1 Baseline clinical characteristics and laboratory variables in women with and without HDP

 Maternal age (y) *

33.6 ± 4.4

33.6 ± 4.3

0.9

 Family history AHT ^†

4 (28.6%)

58 (43.9%)

0.2

 Parity *

1.71 ± 1.4

1.89 ± 0.9

0.5

 Previous history of GDM ^†

1 (7.1%)

19 (14.4%)

0.4

 Previous history of preeclampsia ^†

1 (7.1%)

2 (1.5%)

0.1

 Gestational age at enrollement (w) *

31.2 ± 1.9

31.1 ± 1.9

0.8

 Pregestational BMI (kg/m²) *

30.1 ± 6.8

26.0 ± 5.0

0.046

 Obesity ^†

8 (57.1%)

28 (21.2%)

0.006

 GDM ^†

11 (78.6%)

67 (50.2%)

0.047

 Insulin treatment ^†

5 (45.4%)

24 (35.8%)

0.2

 Office Systolic BP (mmHg) *

118.5 ± 15.7

109.7 ± 15.4

0.043

 Office Diastolic BP (mmHg) *

74.5 ± 9.7

65.9 ± 9.0

0.001

 ASA prophylaxis ^†

5 (35.7%)

14 (10.6%)

0.008

 Basal glucose (mmol/L) *

4.9 ± 0.5

4.8 ± 0.5

0.039

 HbA1c (%)*

5.2 ± 0.5

4.8 ± 0.3

0.002

 HOMA-IR *

2.9 ± 1.1

2.0 ± 1.3

0.09

 Albumin/creatinine (mg/g) *

28.3 ± 60.0

6.3 ± 6.6

0.1

 Uric acid (mmol/L) *

0.24 ± 0.06

0.22 ± 0.13

0.6

 Total-cholesterol (mmol/L) *

6.52 ± 0.86

6.45 ± 1.19

0.8

 LDL-cholesterol (mmol/L) *

3.76 ± 0.8

3.66 ± 1.22

0.7

 HDL-cholesterol (mmol/L) *

1.99 ± 0.42

1.92 ± 0.47

0.6

 Triglycerides (mmol/L) *

2.2 ± 0.6

2.1 ± 0.8

0.6